Opthea
Presence
Opthea is a company listed under the stock ticker OPT (AU).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Opthea
- Frederic Guerard, Chief Executive Officer
- Quinton Oswald, Non-Executive Director
- Susan Orr, Director
Popular executive movements at Opthea
- John Han has joined the company as Vice President, Medical Affairs (posted on April 9 2024).
- Sujal Shah has joined the company as Director (posted on April 5 2024).
- Arshad Khanani has joined the company as Director (posted on February 20 2024).
Click here to view some more movements at Opthea
Create your alert
to follow the executive moves at Opthea.
Biotechnology
Opthea has 2,285 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Opthea
- Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference | Opthea Limited, Inc
- Press Releases | Opthea Limited, Inc
- Press Releases | Opthea Limited, Inc
- Opthea - Eyewire+
Social media about Opthea
- Opthea on Wikipedia, Google News & Yahoo Finance
- Opthea on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Frederic Guerard 
